RU2019140198A - Method of using elemental mercury for the treatment of cancer - Google Patents

Method of using elemental mercury for the treatment of cancer Download PDF

Info

Publication number
RU2019140198A
RU2019140198A RU2019140198A RU2019140198A RU2019140198A RU 2019140198 A RU2019140198 A RU 2019140198A RU 2019140198 A RU2019140198 A RU 2019140198A RU 2019140198 A RU2019140198 A RU 2019140198A RU 2019140198 A RU2019140198 A RU 2019140198A
Authority
RU
Russia
Prior art keywords
treatment
cancer
elemental mercury
mercury
administration
Prior art date
Application number
RU2019140198A
Other languages
Russian (ru)
Inventor
Григорий Викторович Кулижников
Виктор Григорьевич Кулижников
Original Assignee
Григорий Викторович Кулижников
Виктор Григорьевич Кулижников
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Григорий Викторович Кулижников, Виктор Григорьевич Кулижников filed Critical Григорий Викторович Кулижников
Priority to RU2019140198A priority Critical patent/RU2019140198A/en
Publication of RU2019140198A publication Critical patent/RU2019140198A/en

Links

Claims (1)

Способ лечения онкологических заболеваний, включающий парентеральный путь введения ртути, отличающийся тем, что используется парентеральный путь введения элементарной ртути, которая выполнена в виде жидкости, которую вводят в дозировке от 3,5 мг на 1 кг веса больного для создания депо, обеспечивающего необходимую концентрацию ртути в крови.A method for the treatment of oncological diseases, including the parenteral route of administration of mercury, characterized in that the parenteral route of administration of elemental mercury is used, which is made in the form of a liquid, which is administered at a dosage of 3.5 mg per 1 kg of the patient's weight to create a depot providing the required concentration of mercury in blood.
RU2019140198A 2019-12-09 2019-12-09 Method of using elemental mercury for the treatment of cancer RU2019140198A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2019140198A RU2019140198A (en) 2019-12-09 2019-12-09 Method of using elemental mercury for the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2019140198A RU2019140198A (en) 2019-12-09 2019-12-09 Method of using elemental mercury for the treatment of cancer

Publications (1)

Publication Number Publication Date
RU2019140198A true RU2019140198A (en) 2021-06-09

Family

ID=76296254

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019140198A RU2019140198A (en) 2019-12-09 2019-12-09 Method of using elemental mercury for the treatment of cancer

Country Status (1)

Country Link
RU (1) RU2019140198A (en)

Similar Documents

Publication Publication Date Title
RU2017134443A (en) METHOD OF TREATMENT WITH USE OF TRADIPTANT
RU2017132877A (en) COMBINATION OF PD-1 ANTAGONIST AND ERIBULIN FOR CANCER TREATMENT
EA201690069A1 (en) THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE
EA201492010A1 (en) APPLICATION OF HIGH DOSE OF LACHINIMODE FOR TREATMENT OF MULTIPLE SCLEROSIS
RU2015134581A (en) NITROXIL DONORS WITH IMPROVED THERAPEUTIC INDEX
JP2015532296A5 (en)
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
MX2021002321A (en) Novel methods.
MX2019008489A (en) Treatment comprising oral or gastric administration of edaravone.
RU2015145997A (en) ANTITUMORIC MEDICINE, INCLUDING LOW-DOSED IRINOTECANE HYDROCHLORIDE HYDRATE
PE20181332A1 (en) METHODS OF SEDATION AND PARENTERAL FORMULATION FOR USE DURING THE TREATMENT OF CRITICAL CARE
EA202090242A1 (en) TREATMENT OF FABRY DISEASE IN FZT-NAIVE AND FZT-TREATED PATIENTS
FI3383385T4 (en) Melflufen dosage regimens for cancer
MX2022000143A (en) Novel methods.
RU2014137190A (en) COMBINATIONS OF HISTON-DEACETHYLASE AND PAZOPANIBA INHIBITOR AND THEIR APPLICATION
RU2007132971A (en) METHODS AND MATERIALS WITH TRANS-CLOMIPHENES FOR TREATMENT OF MEN'S INFERTILITY
RU2012108144A (en) ANTI-CANCER THERAPY DIRECTED AGAINST CANCER STEM CELLS AND CANCER FORMS RESISTANT TO TREATMENT BY MEDICINES
PH12019500516A1 (en) Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof
RU2019140198A (en) Method of using elemental mercury for the treatment of cancer
RU2018114457A (en) TREATMENT OF SYD985 PATIENTS WITH T-DM1 REFRACTORY CANCER
JP2015510945A5 (en)
AR111803A1 (en) DERIVED FROM CICLOPENTAN [G] QUINAZOLIN-4-ONA AND ITS EMPLOYMENT IN THE TREATMENT OF CANCER RESISTANT TO PLATINUM
JP2020535180A5 (en)
JP2020040998A5 (en)
MX2021007324A (en) Oral therapy using 6,8-bis-benzylthio-octanoic acid.